Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
AstraZeneca PLC (GB:AZN)
LSE:AZN
AstraZeneca (AZN) Share Price & Analysis
284 Followers
AZN Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range9,314.90p - 12,079.25p
Previous Close11,268p
Volume354.56K
Average Volume (3M)2.87M
Market Cap
£174.68B
Enterprise Value193.12B
Total Cash (Recent Filing)$5.84B
Total Debt (Recent Filing)$28.62B
Price to Earnings (P/E)36.4
Beta0.86
Next Earnings
Apr 25, 2024EPS Estimate
£1.55Last Dividend Ex-Date
Feb 22, 2024Dividend Yield2.02%
Share Statistics
EPS (TTM)3.10
Shares Outstanding1,550,189,338
10 Day Avg. Volume2,944,327
30 Day Avg. Volume2,873,868
Standard Deviation0.06
R-Squared0.09
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-11.60
Price to Sales (P/S)486.49
Price to Cash Flow (P/CF)20.10
P/FCF Ratio25.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.35
Enterprise Value/Gross Profit5.14
Enterprise Value/Ebitda21.26
Forecast
1Y Price Target
11,722.33pPrice Target Upside3.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering18
AstraZeneca News
Bulls Say, Bears Say
Bulls Say
Company OutlookThe company has a robust pipeline with five game-changing Phase III trials that could significantly increase sales.
Dividend PolicyDividend increase of 7% for FY24 signals management's responsiveness to investor concerns.
Investor ExpectationsAnalyst expects AZN to issue a new mid-term guide significantly above consensus.
Bears Say
Dividend ConcernsThe dividend is flat - another disappointment after a flat decade and two years of minor nudges.
Earnings PerformanceShares have been underperforming due to factors such as near-term EPS momentum and misinterpreted margin comments.
Product PerformanceRecent product performance has seen misses in the fourth quarter, raising questions about specific product dynamics.
---
AZN FAQ
What was AstraZeneca PLC’s price range in the past 12 months?
AstraZeneca PLC lowest share price was 9314.90p and its highest was 12079.25p in the past 12 months.
What is AstraZeneca PLC’s market cap?
Currently, no data Available
When is AstraZeneca PLC’s upcoming earnings report date?
AstraZeneca PLC’s upcoming earnings report date is Apr 25, 2024 which is tomorrow.
How were AstraZeneca PLC’s earnings last quarter?
AstraZeneca PLC released its earnings results on Feb 08, 2024. The company reported 1.172p earnings per share for the quarter, missing the consensus estimate of 1.182p by -0.01p.
Is AstraZeneca PLC overvalued?
According to Wall Street analysts AstraZeneca PLC’s price is currently Undervalued.
Does AstraZeneca PLC pay dividends?
AstraZeneca PLC pays a Annually dividend of 156p which represents an annual dividend yield of 2.02%. See more information on AstraZeneca PLC dividends here
What is AstraZeneca PLC’s EPS estimate?
AstraZeneca PLC’s EPS estimate is £1.55.
How many shares outstanding does AstraZeneca PLC have?
AstraZeneca PLC has 1,550,231,100 shares outstanding.
What happened to AstraZeneca PLC’s price movement after its last earnings report?
AstraZeneca PLC reported an EPS of 1.172p in its last earnings report, missing expectations of 1.182p. Following the earnings report the stock price went down -6.358%.
Which hedge fund is a major shareholder of AstraZeneca PLC?
Currently, no hedge funds are holding shares in GB:AZN
---
AstraZeneca Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
11,722.33p (3.27% Upside)
11,722.33p (3.27% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-5.47%
12-Months-Change
Fundamentals
Return on Equity
15.60%
Trailing 12-Months
Asset Growth
-1.11%
Trailing 12-Months
Company Description
AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
---
AZN Stock 12 Months Forecast
Average Price Target
11,722.33p
▲(3.27% Upside)
Technical Analysis
Best Analysts Covering AZN
1 Year
1 Year Success Rate
28/34 ratings generated profit
1 Year Average Return
+12.19%
reiterated a buy rating 10 days ago
Copying Emily Field's trades and holding each position for 1 Year would result in 82.35% of your transactions generating a profit, with an average return of +12.19% per trade.
---